mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.6 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
0.083 |
0.6 |